Elsevier

Experimental Neurology

Volume 154, Issue 2, December 1998, Pages 663-672
Experimental Neurology

Regular Article
Regional Specificity of Brain Atrophy in Huntington's Disease

https://doi.org/10.1006/exnr.1998.6919Get rights and content

Abstract

The present study analyzes the relationship between cortical and subcortical brain volumes in patients with Huntington's disease. The brains of seven patients with a clinical diagnosis and positive family history of Huntington's disease and 12 controls were collected at autopsy with consent from relatives. Detailed clinical assessments were available for all study subjects with genotype confirmation for patients with Huntington's disease. Volume analysis of the brain on serial 3-mm coronal slices was performed as previously described. All patients with Huntington's disease exhibited significant brain atrophy resulting from volume reductions in both cortical and subcortical grey matter. Atrophy of the cortex was relatively uniform, although the medial temporal lobe structures were spared. The caudate nucleus and putamen were strikingly reduced in all cases and this atrophy correlated with the severity of cortical atrophy, suggesting an associated disease process. The rate of cortical but not subcortical atrophy correlated with CAG repeat numbers. Loss of frontal white matter correlated with both cortical and striatal atrophy. Age of onset of chorea correlated with the amount of subcortical atrophy, while duration of chorea correlated negatively with atrophy of the white matter. These results suggest a more widespread and global disease process in patients with Huntington's disease.

References (55)

  • E.H. Aylward et al.

    Basal ganglia volume and proximity to onset in presymptomatic Huntington disease

    Arch. Neurol.

    (1996)
  • E.H. Aylward et al.

    Longitudinal change in basal ganglia volume in patients with Huntington's disease

    Neurology

    (1997)
  • L. Bäckman et al.

    Cognitive deficits in Huntington's disease are predicted by dopaminergic PET markers and brain volumes

    Brain

    (1997)
  • K.A. Bamford et al.

    Clinical-pathological correlation in Huntington's disease: A neuropsychological and computed tomography study

    Neurology

    (1989)
  • S. Berent et al.

    Positron emission tomographic scan investigations of Huntington's disease: Cerebral metabolic correlates of cognitive function

    Ann. Neurol.

    (1988)
  • H. Braak et al.

    Allocortical involvement in Huntington's disease

    Neuropathol. Appl. Neurobiol.

    (1992)
  • M. Cudkowicz et al.

    Degeneration of pyramidal projection neurons in Huntington's disease cortex

    Ann. Neurol.

    (1990)
  • S.M. de la Monte et al.

    Morphometric demonstration of atrophic changes in the cerebral cortex, white matter and neostriatum in Huntington's disease

    J. Neuropathol. Exp. Neurol.

    (1988)
  • M. DiFiglia et al.

    Aggregation of Huntington in neuronal intranuclear inclusions and dystrophic neurites in brain

    Science

    (1997)
  • K.L. Double et al.

    Regional brain atrophy in idiopathic Parkinson's disease and diffuse Lewy body disease

    Dementia

    (1996)
  • I. Ferrer et al.

    Parvalbumin-immunoreactive neurons in the cerebral cortex and striatum in Huntington's disease

    Neurodegeneration

    (1994)
  • S. Furtado et al.

    Relationship between trinucleotide repeats and neuropathological changes in Huntington's disease

    Ann. Neurol.

    (1996)
  • I. Gourfinkel-An et al.

    Differential distribution of normal and mutated forms of Huntington in the human brain

    Ann. Neurol.

    (1997)
  • V. Hahn-Barma et al.

    Are cognitive changes the first symptoms of Huntington's disease? A study of gene carriers

    J. Neurol. Neurosurg. Psychiatry

    (1998)
  • L. Harms et al.

    Decreased N-acetyl-aspartate/choline ratio and increased lactate in the frontal lobe of patients with Huntington's disease: A proton magnetic resonance spectroscopy study

    J. Neurol. Neurosurg. Psychiatry

    (1997)
  • G.J. Harris et al.

    Single photon emission computed tomographic blood flow and magnetic resonance volume imaging of basal ganglia in Huntington's disease

    Arch. Neurol.

    (1996)
  • M.R. Hayden et al.

    The combined use of positron emission tomography and DNA polymorphisms for preclinical detection of Huntington's disease

    Neurology

    (1987)
  • Cited by (200)

    • N-terminal mutant huntingtin deposition correlates with CAG repeat length and symptom onset, but not neuronal loss in Huntington's disease

      2022, Neurobiology of Disease
      Citation Excerpt :

      The potential applications of this finding were further highlighted when a negative correlation was found between mutant Htt in the cerebrospinal fluid of late-stage HD patients and symptom onset, therefore Htt detection may be used as a diagnostic tool to predict the clinical onset of HD (Southwell et al., 2015). As previously reported and confirmed within our HD cohort (Supplementary Fig. 1) there is a well-established negative relationship between CAG repeat length and the onset of symptoms, and the results from this study suggest a critical role for Htt aggregates in the underlying pathological mechanism driving HD clinical presentation (Andrew et al., 1993; Duyao et al., 1993; Halliday et al., 1998). There was no significant relationship between the number of MAB5374+, MW1+, or EPR5526+ Htt aggregates and the density of SMI-32+ pyramidal cells in the MTG TMA, which suggests the number of aggregates does not correlate with pyramidal cell loss.

    • Measuring movement in health and disease

      2022, Brain Research Bulletin
    • The microbiota-gut-brain axis in Huntington's disease

      2022, International Review of Neurobiology
    View all citing articles on Scopus

    A. B. JosephR. R. Young

    View full text